In this educational webinar, experts will discuss two key publications in the field of neovascular age-related macular degeneration and diabetic macular edema. Central to this 60-minute session are two publications on four phase III studies: 

• one publication discusses the results of faricimab in neovascular age-related macular degeneration based on the TENAYA and LUCERNE study.
• The other publication reviews the results of faricimab in diabetic macular edema based on the YOSEMITE and RHINE study. 

Experts discuss the design and results of the four studies and the possible consequences for Dutch practice using case histories. During the broadcast, Prof. Dr. Frank Holz will share his experience with faricimab via a live connection to Germany. 

Experts on faricimab in nLMD and DME

• Prof. Dr. Frank Holz - Professor of Ophthalmology, University Hospital Bonn, Germany
• Dr. Yara Lechanteur - Ophthalmologist, Radboudumc, Nijmegen.
• Dr. Manon van Hecke - Ophthalmologist, Elisabeth Tweesteden Hospital, Tilburg
• Drs. Sankha Amarakoon - Ophthalmologist, Maastricht UMC+

This webinar is open only to ophthalmologists, hospital pharmacists and physician assistants with ophthalmology as a subspecialty or area of interest who are prescribing physicians.